ea0016p791 | Thyroid | ECE2008
Lacka Katarzyna
, Kucharska Aleksandra
, Rajewska-Rager Aleksandra
, Jaracz Jan
Background: TSH-suppressive therapy is widely used in treatment of thyroid differentiated carcinoma. A common consequence of therapy is subclinical hyperthyroidism which may cause dysfunction of cardiovascular system, metabolism and reduction of bone mass1. Thyroid hormones are also involved in regulation of brain function2. Therefore, it is not surprising that thyroid dysfunctions are associated with frequent comorbid cognitive dysfunctions and depressio...